SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

SafetyLit Journal Details

We are unable to provide photocopies of any the articles and reports abstracted in SafetyLit updates. Where possible, links have been provided to the publisher of the material and contact information for the corresponding author is listed. Please consider asking your library to subscribe to the journals from which these abstracts have been gathered.

To recommend a journal for this list please: Send SafetyLit an Email Message


Journal of clinical and translational research

Abbreviation: J. Clin. Transl. Res.

Published by: Whioce publishing

Publisher Location: Singapore, Singapore, Republic of

Journal Website:
http://www.jctres.com


Range of citations in the SafetyLit database: 2016; 2(4) -- 2022; 8(5)

Publication Date Range: 2015 --

Title began with volume (issue): 1(1)

Number of articles from this journal included in the SafetyLit database: 11
(Download all articles from this journal in CSV format.)

pISSN = 2382-6533 | eISSN = 2424-810X
OCLC = 950972016


Find a library that holds this journal: http://worldcat.org/issn/23826533

Journal Language(s): English


Aims and Scope (from publisher): The Journal of Clinical and Translational Research (JCTR) is an open access, peer-reviewed, multidisciplinary scientific journal that publishes studies with at least an ex vivo, in vivo, or clinical component. The published research is centered on any clearly defined clinical problem, which may comprise a disease or the basis of disease, a form of therapy or intervention, and clinical diagnostics or prognostics. Articles (original research, reviews, technical reports, medical hypotheses, commissioned articles, special issue articles, and editorials) are published continuously online and bimonthly in print. Studies performed in cells only will generally not be accepted unless they contain critical data that are in line with the scope of the journal. Some examples of such studies include molecular pathways that lie at the basis of a disease, novel biotechnological approaches for e.g., the production of drugs, or new techniques that improve clinical diagnostics and prognostics. Articles that combine preclinical and clinical data are given priority. Contributions from academic institutions and industry are welcome.